Erythropoietin
Active Principle
Recombinant human Eruythropoietin alpha
Presentation
2000 IU
4000 IU
10000 IU
Indication
Treatment of anemia associated with CRF, to elevate or maintain the red blood cell level and to decrease the need for transfusions in these patients.
Class
H